Advertisements

BioPharmX Corporation. Common (BPMX) Stock Quote

Detailed Quote for BioPharmX Corporation. Common (BPMX)
$ 0.2184 r      0.0034 (+1.58%) Volume: 4.8m 3:59 PM EDT 24-May-2018
After Hours:  $ 0.219   0.0006 (+0.27%) Volume: 36.26k 7:01 PM EDT 24-May-2018
Today 5d 1m 3m 1y more
Last Price
0.2184
Change $
0.0034
Change %
1.58%
Tick
  
Bid
N/A
Bid Size
0
Ask
N/A
Ask Size
0
Open
0.223
High
0.2342
Low
0.2151
Prev Close
0.215
Last Trade
3:59
Volume
4.8m
52 Wk Hi
0.689999997
52 Wk Low
0.100000001
Market Cap
41.83m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
191,518,731
EPS (TTM)
-0.200000002
PE Ratio
N/A
Exchange
NYSE American
News and Media for BioPharmX Corporation. Common (BPMX)
Sector News | Topic News
News for BioPharmX Corporation. Common (BPMX)
Thu, May 24, 2018
9:00 AM BioPharmX Studies Show Hydrophilic Topical Minocycline Gels May Be the Preferred Treatment Option for Acne, Rosacea Patients - PR Newswire
Thu, May 10, 2018
7:30 AM Factors of Influence in 2018, Key Indicators and Opportunity within Energy Transfer Equity, Mednax, BioPharmX, Owens & Minor, SunPower, and Convergys - New Research Emphasizes Economic Growth - GlobeNewswire
Thu, Apr 26, 2018
4:54 PM BioPharmX Corporation beats by $0.01, beats on revenue - SeekingAlpha
4:15 PM BioPharmX Reports Fourth Quarter and Full Year 2018 Financial Results - PR Newswire
Wed, Mar 21, 2018
8:00 AM Today's Research Reports on Trending Tickers: BioPharmX and MediWound - ACCESSWIRE IA
Tue, Mar 20, 2018
8:30 PM BioPharmX Cancels Presentation at Oppenheimer's 28th Annual Healthcare Conference Due to Severe Weather - PR Newswire
9:15 AM U.S. Patent and Trademark Office Awards BioPharmX Patent Protection for Novel Tetracycline-class Topical Drug Compositions - PR Newswire
Fri, Mar 16, 2018
10:26 AM Key events next week - healthcare (continued #1) - SeekingAlpha
Wed, Mar 14, 2018
9:15 AM BioPharmX to Present at Oppenheimer's 28th Annual Healthcare Conference - PR Newswire
Mon, Mar 05, 2018
9:15 AM BioPharmX to Present at 30th Annual ROTH Conference - PR Newswire
Wed, Feb 07, 2018
8:15 AM Investor Expectations to Drive Momentum within Graphic Packaging Holding, Invitation Home, Teradyne, Dean Foods, Valley National, and BioPharmX - Discovering Underlying Factors of Influence - GlobeNewswire
Fri, Jan 26, 2018
9:15 AM BioPharmX To Present Data On New Fluorescence Lifetime Imaging Microscopy to Measure How Effectively Topically Applied Minocycline Reaches Targets in Skin - PR Newswire
Fri, Jan 12, 2018
9:15 AM BioPharmX To Present BPX-04 Rosacea Data At Two Leading Clinical Conferences This Month - PR Newswire
Tue, Jan 09, 2018
7:40 AM Free Post Earnings Research Report: BioPharmX's Adjusted EPS Beat Expectations - ACCESSWIRE IA
Fri, Dec 15, 2017
7:10 AM Blog Exposure - MabVax Therapeutics Completes Enrollment and Dosing In Initial Cohort of Phase-1 Trial of Its Cancer Drug MVT-1075 - ACCESSWIRE IA
Thu, Dec 07, 2017
4:20 PM BioPharmX Corporation EPS in-line - SeekingAlpha
4:15 PM BioPharmX Reports Third Quarter 2018 Financial Results - PR Newswire
Mon, Dec 04, 2017
9:15 AM BioPharmX Demonstrates Topical Minocycline Gel May Exhibit Relevant Antimicrobial and Anti-inflammatory Properties for the Treatment of Acne at ASCB 2017 - PR Newswire
Tue, Nov 28, 2017
7:43 AM Your Daily Pharma Scoop: Synergy In 2018, Repatha Action Date, Alkermes Signs Deal - SeekingAlpha
Tue, Nov 21, 2017
9:27 AM BioPharmX prices equity offering; shares down 35% premarket - SeekingAlpha
More News for BPMX >>

Tags for BioPharmX Corporation. Common

Research stocks or mutual funds related to BioPharmX Corporation. Common by keywords or tags. Find companies that have a similar focus to BPMX. The keywords below have been associated to BPMX by either user submission or electronic means.